A Randomized, Phase 3, Double-Blind Study of Chemoradiotherapy With or Without Pembrolizumab for the Treatment of High-risk, Locally Advanced Cervical Cancer (KEYNOTE-A18/ENGOT-cx11)

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description


StatusActive
Effective start/end date13/05/2012/05/25

Keywords

  • clinical trial
  • phase 3 study
  • cervical cancer
  • treatment efficacy
  • treatment safety